BLAHO, Martin, Jitka MACHACKOVA, Petr DÍTĚ, Pavol HOLECZY, Petr SEDIVY, Robert PSAR, Zdenek SVAGERA, Dominik VILIMEK, Daniel TOMAN, Ondrej URBAN and Marek BUZGA. Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study. OBESITY SURGERY. NEW YORK: SPRINGER, 2022, vol. 32, No 11, p. 3666-3674. ISSN 0960-8923. Available from: https://dx.doi.org/10.1007/s11695-022-06278-4.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Use of Magnetic Resonance Imaging to Quantify Fat and Steatosis in the Pancreas in Patients after Bariatric Surgery: a Retrospective Study
Authors BLAHO, Martin (203 Czech Republic), Jitka MACHACKOVA (203 Czech Republic), Petr DÍTĚ (203 Czech Republic, belonging to the institution), Pavol HOLECZY, Petr SEDIVY (203 Czech Republic), Robert PSAR (203 Czech Republic), Zdenek SVAGERA (203 Czech Republic), Dominik VILIMEK (203 Czech Republic), Daniel TOMAN (203 Czech Republic), Ondrej URBAN (203 Czech Republic) and Marek BUZGA (203 Czech Republic).
Edition OBESITY SURGERY, NEW YORK, SPRINGER, 2022, 0960-8923.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30219 Gastroenterology and hepatology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.900
RIV identification code RIV/00216224:14110/22:00128219
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s11695-022-06278-4
UT WoS 000859286600001
Keywords in English Obesity; Bariatric surgery; Metabolic syndrome; Pancreatic steatosis
Tags 14110213, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 23/1/2023 12:39.
Abstract
invasive method for diagnosing PS. We investigated the impact of metabolic syndrome (MS) on the presence of PS, differences in individuals with and without PS, and the metabolic effects of bariatric procedures. Methods Changes in anthropometric and basic biochemistry values and MS occurrence were evaluated in 34 patients with obesity who underwent a bariatric procedure. After the procedure, patients underwent MRI with manual 3D segmentation mask creation to determine the pancreatic fat content (PFC). We compared the differences in the PFC and the presence of PS in individuals with and without MS and compared patients with and without PS. Results We found no significant difference in the PFC between the groups with and without MS or in the occurrence of PS. There were significant differences in patients with and without PS, especially in body mass index (BMI), fat mass, visceral adipose tissue ( VAT), select adipocytokines, and lipid spectrum with no difference in glycemia levels. Significant metabolic effects of bariatric procedures were observed. Conclusions Bariatric procedures can be considered effective in the treatment of obesity, MS, and some of its components. Measuring PFC using MRI did not show any difference in relation to MS, but patients who lost weight to BMI < 30 did not suffer from PS and had lower overall fat mass and VAT. Glycemia levels did not have an impact on the presence of PS.
PrintDisplayed: 6/8/2024 06:18